0 NASDAQ Companies - July 22, 2019Peak Resorts to be Acquired by Vail Resorts for $11.00 Per ShareRead More
0 NASDAQ Companies - July 22, 2019FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary FibrosisRead More
0 NASDAQ Companies - July 22, 2019Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS PatientsRead More
0 NASDAQ Companies - July 22, 2019MediWound Launches EscharEx® U.S. Clinical Development ProgramRead More
0 NASDAQ Companies - July 22, 2019Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical AssessmentRead More
0 NASDAQ Companies - July 22, 2019Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People OfficerRead More
0 NASDAQ Companies - July 22, 2019Achillion’s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy VolunteersRead More
0 TSX News - July 22, 2019Colabor Announces the Date of its 2019 Second Quarter Results Conference CallRead More
0 TSX Venture News - July 22, 2019Peeks Social Provides Update on Status of Management Cease Trade OrderRead More
0 TSX Venture News - July 22, 2019Fura Announces Update on Australian Sapphire Mining Project AcquisitionRead More
